Parvovirus B19: a cause for aplastic crisis and hemophagocytic lymphohistiocytosis.
Yilmaz
S
S
Department of Pediatric Hematology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Oren
H
H
Demircioğlu
F
F
Firinci
F
F
Korkmaz
A
A
Irken
G
G
D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications* / Q000473:pathology / Q000628:therapy; D000914:Antibodies, Viral / Q000097:blood; D017707:Erythrocyte Transfusion; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D051359:Lymphohistiocytosis, Hemophagocytic / Q000150:complications* / Q000473:pathology / Q000628:therapy; D008297:Male; D010322:Parvoviridae Infections / Q000097:blood / Q000150:complications* / Q000175:diagnosis*; D016732:Parvovirus B19, Human / Q000276:immunology*; D013103:Spherocytosis, Hereditary / Q000150:complications; D016896:Treatment Outcome
D000914:Antibodies, Viral; D005338:Fibrin Fibrinogen Degradation Products; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C036309:fibrin fragment D